ストックスクリーナーアプリを入手
0.2355
0.21%
0.0005
アフターアワーズ：
.23
-0.0055
-2.34%
前日終値:
$0.235
開ける：
$0.23
24時間の取引高:
38.62M
Relative Volume:
0.39
時価総額：
$44.01M
収益：
-
当期純損益:
$-121.02M
株価収益率:
-0.0209
EPS:
-11.26
ネットキャッシュフロー:
$-114.09M
1週間 パフォーマンス:
-15.50%
1か月 パフォーマンス:
-29.47%
6か月 パフォーマンス:
-60.49%
1年 パフォーマンス:
-97.42%
1日の値動き範囲:
$0.2206
$0.2456
1週間の範囲:
$0.216
$0.2875
52週間の値動き範囲:
$0.118
$12.48
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
名前
Tonix Pharmaceuticals Holding Corp
セクター
電話
212-980-9155
住所
26 MAIN STREET, SUITE 101, CHATHAM, NY
TNXP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
0.2355 | 44.01M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-04-18 | 開始されました | Noble Capital Markets | Outperform |
| 2019-04-18 | アップグレード | ROTH Capital | Neutral → Buy |
| 2017-08-18 | アップグレード | ROTH Capital | Neutral → Buy |
| 2016-09-07 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2016-02-17 | 繰り返されました | Oppenheimer | Outperform |
| 2015-11-04 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-06-12 | 開始されました | Oppenheimer | Outperform |
| 2015-02-17 | 繰り返されました | ROTH Capital | Buy |
| 2014-09-29 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tonix Pharmaceuticals Holding Corp (TNXP) 最新ニュース
Tonix Pharmaceuticals Holding (LTS:0A4T) Liabilities-to-Ass - GuruFocus.com
Tonix Pharmaceuticals Holding (LTS:0A4T) Price-to-Operating-Cash-Flow : (As of Jan. 17, 2025) - GuruFocus.com
FDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SL - MSN
Tonix Pharmaceuticals Holding (LTS:0A4T) Net Income : $-135.25 Mil (TTM As of Sep. 2024) - GuruFocus.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Hold Rating from Analysts at StockNews.com - Defense World
Tonix Pharmaceuticals Holding (LTS:0A4T) Altman Z-Score : -14.06 (As of Jan. 16, 2025) - GuruFocus.com
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Tonix Pharmaceuticals Holding (LTS:0A4T) 9-Day RSI : N/A (As of Jan. 15, 2025) - GuruFocus.com
Rivoluzionare la salute con i virus? Una nuova era per le scoperte biotecnologiche - Be3
(TNXP)Analyzing Tonix Pharmaceuticals's Short Interest - Benzinga
Revolutionizing Health with Viruses? A New Age for Biotech Breakthroughs - Be3
Tonix Pharmaceuticals Further Strengthens Commercial - GlobeNewswire
Tonix Pharma Announces Key Appointment and Study Timelines - TipRanks
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access - The Manila Times
Tonix Pharmaceuticals Strengthens Commercial Team Ahead of Critical FDA Decision on Fibromyalgia Drug - StockTitan
Tonix Is A Buy For Potentially Great Return On PTSD Breakthrough, Part 2 (NASDAQ:TNXP) - Seeking Alpha
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.2%Time to Sell? - MarketBeat
Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase Transcript - GuruFocus.com
Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences - The Manila Times
Tonix Pharmaceuticals CEO to Present Pipeline Updates at Major Neuroscience and Biotech Forums - StockTitan
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 2.5%Time to Buy? - MarketBeat
SABBY MANAGEMENT, LLC Acquires 1,306,313 Shares in Tonix Pharmaceuticals Holding Corp - GuruFocus.com
What’s Next for TNXP? The Future of Biotech and Stock Surges - Be3
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.5%What's Next? - MarketBeat
Tonix Receives PDUFA Goal Date for Sleep-Enhancing Fibromyalgia Drug Candidate - Sleep Review
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.5%What's Next? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 8.4%Time to Sell? - MarketBeat
Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024 - MSN
Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by StockNews.com - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.8%Should You Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 5.3%What's Next? - MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 151.6% in December - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 8.7%Time to Sell? - MarketBeat
This Micro Cap Is Getting Bid Up Prior To Opening Bell - MSN
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 2.6%Should You Sell? - MarketBeat
Certain Options of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com
Certain Common Stock of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.4%Time to Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.2%What's Next? - MarketBeat
FDA sets review goal date for Tonix fibromyalgia drug By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 26.8%Should You Sell? - MarketBeat
Tonix Pharma Awaits FDA Decision on TNX-102 SL - TipRanks
FDA sets review goal date for Tonix fibromyalgia drug - Investing.com
Tonix Pharmaceuticals Announces PDUFA Goal Date of August - GlobeNewswire
Tonix Pharmaceuticals' Groundbreaking Fibromyalgia Drug Gets FDA Fast Track & PDUFA Date - StockTitan
StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) - MarketBeat
Tonix Pharmaceuticals ups offering to $250 million - Investing.com India
Tonix Pharmaceuticals Holding Corp (TNXP) 財務データ
収益
当期純利益
現金流量
EPS
0.65%
4.62%
大文字化:
|
ボリューム (24 時間):